Related Experiment Video
Updated: Oct 11, 2025

10:29
Generation of Human Chimeric Antigen Receptor Regulatory T Cells
Published on: January 3, 2025
1.7K
CAR T-Cell Therapy: Is CD28-CAR Heterodimerization Its Achilles' Heel?
Leonardo M R Ferreira1,2, Yannick D Muller3
1Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC, United States.
Frontiers in Immunology
|December 6, 2021
Abstract
No abstract available in PubMed .
Keywords:
CD19 CAR T-cellCD28chimeric antigen receptorcytokine release syndromeheterodimerizationimmune effector cell-associated neurotoxicity syndromeneurotoxicitytransmembrane domainMore Related Videos
Related Concept Videos
T Cell Activation and Clonal Selection
8.5K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
8.5K
Tumor Immunotherapy
725
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
725

